Charles V. Pollack, MD, is a veteran medical professional currently heading CGP Consulting, PC, in the greater Philadelphia area. Leveraging nearly 40 years of clinical and research experience, Charles V. Pollack, MD, works with several pharmaceutical and biotech companies, leading or assisting with drug development programs. His primary interests include thrombosis, antithrombotic therapy, and the management of atrial fibrillation. In addition to his consulting work.
Dr. Pollack is a clinician-scientist at the University of Mississippi Medical Center. He has been part of the institution’s faculty since 2019, and has served two terms as president of the University of Mississippi Medical Research Foundation. Dr. Pollack has won the highest research and teaching awards from the American College of Emergency Physicians, and is the first US emergency medicine physician to be named a fellow of the European Society of Cardiology.
A diplomate of the American Board of Emergency Medicine, Dr. Pollack is licensed to practice in multiple states. He was previously affiliated with Thomas Jefferson University Hospital, Pennsylvania Hospital, Arizona Heart Hospital, and Maricopa Medical Center. He has also worked with PhaseBio Pharmaceuticals, VERO Biotech, and Transition Patient Services.
Dr. Pollack has led or contributed to over 500 publications. He further serves on the editorial board of Journal of Emergency Medicine and Clinical Cardiology and is a reviewer for multiple peer-reviewed journals. He earned his MD from Tulane University, and completed his residency at the University of Mississippi.